chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist concerning a 20 year old female who on 25-JAN-2007 was vaccinated with a second dose of HPV vaccine (yeast) 0.5 ml intramuscularly.  Subsequently the patient experienced joint and bone pain. The patient sought unspecified medical attention.  The patient is recovering from joint and bone pain. Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/14/2007. Initial and follow-up information has been received from a pharmacist concerning a 20 year old female with no known drug allergies who on 07-NOV-2006 was vaccinated with a first dose of GARDASIL intramuscularly in the deltoid. On 11-JAN-2007 (also reported as 24-JAN-2007), the patient was vaccinated with the second dose of GARDASIL (Lot number 654510/0962F) 0.5 ml intramuscularly in the deltoid. Concomitant therapy included APRI ORD and AUGMENTIN. On 12-JAN-2007 the patient experienced joint stiffness, bone pain and severe joint pain. On 26-JAN-2007, the patient recovered from joint stiffness, bone pain and severe joint pain. Additional information is not expected.
Employee recieved 4 vaccines, Hep B, Td, MMR, and PPD. 30mins after, she came back complaining of dizziness and light headedness. Employee denies tightness in chest; no swelling noted on injection sites; purplish discoloration noted on the right palm with slight swelling; B/P 125/81, pulse98, respirations 14. 911 called, employee evaluated by Emergency Medical Personnel and was transported to Hospital, where she was discharged a few hours later.
FEVER; This solicited report received from a patient: Adverse Event Rates RECOVER concerned a 27 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on AUG-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and fever was related.  This report was non-serious.
Employee presented to Employee Health nurse with complaint of a fine non-raised rash to upper body. Complained of edema to both knees. Blister to inner thigh.
Pt was very nervous to receive vaccine, she was teary eyed and anxious. Her father was present. She sat while receiving the vaccine. I had her count to 10 and then gave the vaccine. She then said she felt dizzy and passed out for a few seconds. I held her shoulders so that she remained in the chair. Once she was steady I had a technician get her an orange juice and I had her dad keep an eye on her while I quickly grabbed her an ice pack. I sat with her for 15 minutes along with her parent and observed her feeling better, The patient and father both said this is a typical reaction to vaccines for her.
Pt recvd vax on 12MAR93 & exp loss of appetite & was presented back to MD office; MD felt child was fine; 13MAR92 the pt was found dead;
Sore arm and shoulder by noon on 4/14/2021. Chills, bone aches, fever and numb fingertips around 7:00 pm same day.
ANAPHYLACTIC SHOCK; This spontaneous report received from a consumer concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: blood clots. The patient previously received with covid-19 vaccine ad26. cov2.s (dose number in series 1) (suspension for injection, intramuscular and batch number and expiry date were not reported) dose was not reported, 1 total administered on 04-MAY-2021 for a prophylactic vaccination. No concomitant medications were reported. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s. The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number and expiry date were not reported) dose was not reported, 1 total administered on 22-OCT-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced anaphylactic shock (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of anaphylactic shock was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220524087-covid-19 vaccine ad26.cov2.s-Anaphylactic shock. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Pain in the elbow, I can't bend my arm and it hurts when any kind of pressure on it, really weird; Pain in the elbow, I can't bend my arm and it hurts when any kind of pressure on it, really weird; Pain in the elbow, I can't bend my arm and it hurts when any kind of pressure on it, really weird; This is a spontaneous report from a contactable consumer (patient). A 30-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EW0183; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 14May2021 (at the age of 30-years-old) as dose 1, single for covid-19 immunisation. Medical history and concomitant medications included none. The patient experienced pain in the elbow, cannot bend arm and it hurts when any kind of pressure on it, really weird on an unspecified date in 2021. Patient got Pfizer first dose on last Friday (14May2021). When she bent my elbow, got pretty decent pain and that arm really weird, but she did not do any extreme work or activity, was never hurt like this before. Had pain in the elbow and cannot bend my arm and it hurts when any kind of pressure on it. Patient stated, I called urgent care then they told me to call this# that's why I am calling you. Patient stated that there was no expiration date and did not know. The patient did not see NDC# and UPC#. Had vaccine dose in left upper arm. Patient did not take any treatment. The patient stated still having the problem (event). When probed for event outcome, consumer stated, "I really this morning." Investigation assessments include none. Clinical outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.  Follow-up attempts have been completed and no further information is expected.
23 year old male with a history of 31 allergic reactions, Mast cell activation syndrome, Addisons disease, and POTS, developed anaphylactic reaction after receiving first Pfizer COVID-19 vaccine.   Patient took 50 mg benadryl 30 minutes before arriving at vaccine clinic in anticipation of possible reaction per physician's recommendation. Per pt he asked multiple physicians regarding receiving the covid vaccine and was given the permission to proceed.  Also took 20mg hydrocortisone in the morning, then 10mg this afternoon for Addison's disease.   1603 - Pt received 1st dose of Pzifer covid-19 vaccine and during the first 5 minutes of observation complained of feeling itchy and wheezing, light headed, nauseous.    1608 - 0.3mg epi given at - self administered right thigh.   1613 - 90 mg of hydrocortisone (solu-cortef), patient's own medication, given by RN through pt's PICC line RUE; line was flushed with NS before and after and cleaned with alcohol swab.    1615 - Self-administered 4 mg Zofran (patient's own medication) at 1615 into the RUE PICC; cleaned with alcohol swab.   1615- Second 0.3mg of epi given- self administered left thigh.   1617 - Fire department arrived.   1621- pt complains of itchiness still but wheezing is reduced.    BP 118/83 at 4:25 PM, normal O2 sat and pulse, normal respiratory rate.   1626 - patient placed in gurney, escorted out by Fire Dept en route to Hospital   Physician assistant and five other RN were with the patient and his mother.
Grapefruit size swelling: area warm to touch;  MD visit with treatment with Benadryl P O
Severe HA, muscle pain, fever, chills, nausea,  stomach pains, shortness of breath, cough, sore arm and breast
pt exp 2 lesions on face p/being exposed to the vaccinated mom who had a similar exp WAES97120193;It was reported that the child was not vaccinated w/varicella vax;
No adverse event; Temperature excursion occurred on 29 Nov 2022. A total of 16 doses were administered on 29 Nov 2022 (5), 30 Nov 2022 (4), 1 Dec 2022 (2), 2 Dec 2022 (2), 3 Dec 2022 (1), and 5 Dec 2022 (2); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29 Nov 2022. A total of 16 doses were administered on 29 Nov 2022 (5), 30 Nov 2022 (4), 1 Dec 2022 (2), 2 Dec 2022 (2), 3 Dec 2022 (1), and 5 Dec 2022 (2)) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Nov-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29 Nov 2022. A total of 16 doses were administered on 29 Nov 2022 (5), 30 Nov 2022 (4), 1 Dec 2022 (2), 2 Dec 2022 (2), 3 Dec 2022 (1), and 5 Dec 2022 (2)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29 Nov 2022. A total of 16 doses were administered on 29 Nov 2022 (5), 30 Nov 2022 (4), 1 Dec 2022 (2), 2 Dec 2022 (2), 3 Dec 2022 (1), and 5 Dec 2022 (2)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29 Nov 2022. A total of 16 doses were administered on 29 Nov 2022 (5), 30 Nov 2022 (4), 1 Dec 2022 (2), 2 Dec 2022 (2), 3 Dec 2022 (1), and 5 Dec 2022 (2)).    No Concomitant medications were provided.  It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that temperature excursion was occurred on 29 Nov 2022. A total of 16 doses were administered on 29 Nov 2022 (5), 30 Nov 2022 (4), 1 Dec 2022 (2), 2 Dec 2022 (2), 3 Dec 2022 (1), and 5 Dec 2022 (2).   No treatment medications were provided.
Headache, Myalgia, Arthralgia, Fever, fatigue Narrative:  Other Relevant History:
Back of R upper arm - redness area 8cm x 4cm with slight edema, pain at site - SQ injection of Varicella
HEADACHE; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's past medical history included sars-cov-2 semi quantitative total antibody test, and concurrent conditions included flu vaccine allergy, ciprofloxacin allergy, no alcohol use, and non-smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced headache. On 07-MAY-2021, Laboratory data included: SARS-CoV-2 test positive (NR: not provided) 2500 U/mL. The action taken with covid-19 vaccine was not applicable. The patient recovered from headache on APR-2021. This report was non-serious.
pt recv vax; began having soreness and difficulty chewing on rt side of mouth; soreness and stiffness is interfering with eating and awakens pt at night;
Patient had a little nausea this morning. Presented today with left shoulder tender and mildly swelling.  No redness noted or fever reported.  Able to move shoulder in all directions.  Took some Tylenol this morning and is feeling better. This is her 3rd shot in the series.
I woke up on thursday 26th and my body was achy.  I went to school, I am a teacher and coach, and continued to feel worse.  All of my joints where hurting and my muscles ached.  About 10:00 am I felt like in need to throw up as I left my classroom, I felt like I was about to pass out.  I made my way to a fellow teachers room, waved at them for help and laid on the floor.  He move me to an office where our school nurse, athletic trainer, and head nurse soon arrived.  My blood pressure was 60/40 and O2 levels in the 60's.  I became incoherent, and they were forcing me to stay awake.  An AED was hooked up to me along with oxygen.  I was never shocked, but they said the AED was telling them to shock me.  The paramedics soon arrived but me in the ambulance, started an IV and did and EKG.  I started feeling better and they ran blood work and did a chest x ray and everything came back good.  Friday I stayed home and was very tired and dizzy at times.  My heart rate will drop at time to the 50's it is usually in the 60's.  Saturday they day of this writing I will feel weak and just not right.
Ten minutes post vax the patient complained of feeling shakey and his throat feels tight. The patient was treated with Benadryl.
This case was reported by a healthcare professional and described the occurrence of swelling injection site in a 5-year-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-GSK); Merck; unknown; right arm given on 12 April 2011 at 10:00. Concurrent medications included Tuberculin given on 12 April 2011. On 12 April 2011 at 10:00 the subject received a dose of KINRIX (.5 unknown, unknown, left arm) as the 4th IPV and 5th PV in the series. On 13 April 2011 (during the night, in the early hours of the morning), 1 day after vaccination with KINRIX, the subject experienced swelling injection site and hotness at injection site of a 10-12 centimetre area. The events occurred in the same arm as KINRIX was given (left arm) and were described as a "severe injection site reaction". The subject was seen in the pediatrician's office on 13 April 2011 and was treated with Antibiotic. At the time of reporting the events were unresolved. The healthcare professional considered the events were probably related to vaccination with KINRIX.
Dose 1: 12/21/20 Dose 2: 1/11/21 Booster (dose 3) 10/9/21 End of 10/21 diagnosed with bacterial vaginosis (first ever diagnosis for individual), treated with Metrogel 1/13/22 diagnosed with yeast infection (first ever diagnosis for individual), treated with Diflucan
30 minutes of heart wrenching screams that I have never heard him do before...terrible.
Information has been received from a medical assistant and refers to an unknown number of patients of unknown age and gender. The patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On an unknown date, the patients were vaccinated with an unknown number of improperly stored doses of VAQTA, lot # R002086 and expiration date 22-APR-2019, lot # R006210 and expiration date 22-APR-2019, lot # N026997 and expiration date 10-NOV-2018 (route, exact dose and dose number were not reported) and LIQUID PEDVAXHIB, lot # R000877 and expiration date 24-SEP-2020 (route, exact dose and dose number were not reported) for prophylaxis. No adverse effects were reported. The vaccines were exposed to temperature excursion at or above 0 degrees Celsius up to 1 degrees Celsius for 1 hour. The previous excursion was 2 degrees Celsius to 8 degrees Celsius for 12 hours. The call was because of a data logger. Follow up information received on 04-FEB-2019. All telephone attempts to obtain follow-up information have been unsuccessful.
p/noon on 15JUN92 red raised rash began on neck line; the rash spread rapidly, exp to upper torso; eyes reddened & lids became swollen & eyes were almost closed; rash itchy, irritable;
Systemic: Chest Tightness/ Heaviness/ Pain-Severe, Systemic: Flushed/ Sweating-Severe, Systemic: Heart Attack-Severe, Systemic: Nausea-Severe
Client is resident of skilled nursing home. Health department came in with 2 nurses and 2 support clerks along with 2 employees from facility to vaccinate residents. Large facility. Each nurse, clerk, and facility employee team started on the opposite ends of the building.  The teams met in the middle of the hallway. A miscommunication lead to client receiving the Covid booster twice within a few minutes. One nurse was in another room giving a vaccine while said client was vaccinated by the other team nurse, who then vaccinated an employee in the hallway a few doors down from the client. At which time the other nurse finished vaccinating client across the hall and entered into patient's room and vaccinated him. 1st nurse used fabric brown rectangle bandage. 2nd nurse used circle dot cartoon bandaid. Residents in the facility had been vaccinated for the flu on 10/26/22 by the facility using fabric rectangle bandaids, many of which were still in place on residents as observed by the health department nurses.  Email was sent to director of skilled nursing facility on 11/3/2022 from Immunization director. No response received. Phone call to facility to speak with facility employee who assisted with Covid vaccination effort occurred 11/4/2022 at 1230 pm. Employee stated no adverse response from client. Stated chart shows that client did not run fever or experience body aches the afternoon/evening of 11/3/2022 or morning of 11/4/2022.  No tests or other treatments were done. Client's cognitive assessment on 11/4/2022 by facility employee who was part of team on 11/03/2022 remains the same according to employee.
She developed mild swelling of her lips just after midnight on 3/3/21, which she discovered after waking up to use the restroom. She then went back to sleep. She awoke the next morning (3/3/21) to find her lips, tongue, and back of her throat were swollen so much that she couldn't talk. She came to the ED where she received 125mg Solu-Medrol , Pepcid 20mg, and Benadryl 25mg. The swelling initially improved then worsened again and she was admitted to the hospital for overnight observation. Swelling improved and she was discharged on 3/4/21.
I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday; I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday) and AGEUSIA (I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANOSMIA (I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday) and AGEUSIA (I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday). At the time of the report, ANOSMIA (I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday) and AGEUSIA (I lost taste and smell when I had covid - lasted about 6 weeks.  Happened again after first vaccine and was still the case when I got the second one yesterday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment medications were reported
frustrating; This is a spontaneous report from a contactable consumer. This 73-year-old female consumer reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunisation on unknown date. Relevant history and concomitant drugs were unknown. The patient stated she was a little frightened, she needs her medicine, she was getting afraid at the reporting time and it was getting frustrating. She was going to get the second shot of Covid and she was scared to death. Outcome of event was unknown.       Information about lot/batch number has been requested.
Janssen COVID-19 Vaccine EUA Initial pain in injected arm (left) that dissipated after 20 min. Roughly 5hrs. after vaccination: -Fever of 102.5 degrees F, nausea, eye sockets sore, intense throbbing headache, chills, felt like skin was over heating, dizziness, disorientation, intense body aches all over (arms, legs and back felt too sore to move) -Fever broke roughly 24 hours after injection -Treatment involved drinking lots of water, ice compress on forehead, and 1 Tylenol pill
Tingling and numb tongue,  itchy and warm soft palate, metallic taste, raw throat appeared about 1-2 hours after vaccination. Nausea appeared 30 minutes after vaccination.
Pt began wheezing accompanied by fever on the day of vax. Two days post vax, pt continues to have fever and wheezing, parent advised to treat with Motrin and seek medical attention.
Felt lightheaded/dizzy within 60 seconds of receiving shot. This feeling dissipated after 5-10 minutes. Other side effects were expected or listed as common; a sore arm (began day of shot, lasted about 2-3 days) and nausea (began 2 days after shot, lasted 3+ days).